Logo image of AFJKR

AIMEI HEALTH TECHNOLOGY CO L (AFJKR) Stock Overview

USA - NASDAQ:AFJKR - KYG013411338

0.3508 USD
-0.08 (-17.85%)
Last: 10/29/2025, 4:30:06 PM
Fundamental Rating

1

Overall AFJKR gets a fundamental rating of 1 out of 10. We evaluated AFJKR against 0 industry peers in the Unkown industry. AFJKR has a bad profitability rating. Also its financial health evaluation is rather negative. AFJKR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AFJKR was profitable.
AFJKR had a negative operating cash flow in the past year.
AFJKR Yearly Net Income VS EBIT VS OCF VS FCFAFJKR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 1M -1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 4.03%
ROE 4.31%
ROIC N/A
ROA(3y)1.23%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AFJKR Yearly ROA, ROE, ROICAFJKR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 1 -1 2 3

1.3 Margins

AFJKR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AFJKR Yearly Profit, Operating, Gross MarginsAFJKR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

The debt/assets ratio for AFJKR is higher compared to a year ago.
AFJKR Yearly Shares OutstandingAFJKR Yearly Shares OutstandingYearly Shares Outstanding 2022 2024 2M 4M 6M
AFJKR Yearly Total Debt VS Total AssetsAFJKR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that AFJKR is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.03 indicates that AFJKR is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.3
ROIC/WACCN/A
WACCN/A
AFJKR Yearly LT Debt VS Equity VS FCFAFJKR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

AFJKR has a Current Ratio of 0.02. This is a bad value and indicates that AFJKR is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.02 indicates that AFJKR may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
AFJKR Yearly Current Assets VS Current LiabilitesAFJKR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200K 400K 600K 800K

More info and screens

1

3. Growth

3.1 Past

AFJKR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1388.42%, which is quite impressive.
EPS 1Y (TTM)1388.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.59, the valuation of AFJKR can be described as very cheap.
The average S&P500 Price/Earnings ratio is at 27.00. AFJKR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 1.59
Fwd PE N/A
AFJKR Price Earnings VS Forward Price EarningsAFJKR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AFJKR Per share dataAFJKR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AFJKR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AIMEI HEALTH TECHNOLOGY CO L

NASDAQ:AFJKR (10/29/2025, 4:30:06 PM)

0.3508

-0.08 (-17.85%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-11 2025-08-11
Earnings (Next)11-03 2025-11-03
Inst Owners66.97%
Inst Owner ChangeN/A
Ins Owners2.48%
Ins Owner ChangeN/A
Market Cap2.15M
Revenue(TTM)N/A
Net Income(TTM)1.79M
AnalystsN/A
Price TargetN/A
Short Float %0.24%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.59
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.05
P/tB 0.05
EV/EBITDA N/A
EPS(TTM)0.22
EY62.71%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS6.81
TBVpS6.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.8
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 4.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.23%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 0.3
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1388.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3636.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

AIMEI HEALTH TECHNOLOGY CO L / AFJKR FAQ

Can you describe the business of AIMEI HEALTH TECHNOLOGY CO L?

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-01-22. The firm is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The firm do not have any specific business combination under consideration and has not nor has anyone on behalf, directly or indirectly, contacted any prospective target business. The company has not generated any revenues.


What is the current price of AFJKR stock?

The current stock price of AFJKR is 0.3508 USD. The price decreased by -17.85% in the last trading session.


How is the ChartMill rating for AIMEI HEALTH TECHNOLOGY CO L?

AFJKR has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.